Key points are not available for this paper at this time.
A recent paper published in Nature Medicine reported on the Phase I clinical trial of a mitochondria-targeting anti-cancer agent IACS-01059 in patients with acute myeloid leukemia (AML) and solid tumors ....
Neužil et al. (Fri,) studied this question.